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Newcastle Disease Virus HN Protein Alters the Conformation of the
F Protein at Cell Surfaces
Lori W. McGinnes, Kathryn Gravel, and Trudy G. Morrison*
Department of Molecular Genetics and Microbiology/Program in Immunology and Virology, University of Massachusetts Medical
School, Worcester, Massachusetts 01655
Received 29 May 2002/Accepted 18 September 2002
Conformational changes in the Newcastle disease virus (NDV) fusion (F) protein during activation of fusion
and the role of HN protein in these changes were characterized with a polyclonal antibody. This antibody was
raised against a peptide with the sequence of the amino-terminal half of the F protein HR1 domain. This
antibody immunoprecipitated both F0 and F1 forms of the fusion protein from infected and transfected cell
extracts solubilized with detergent, and precipitation was unaffected by expression of the HN protein. In
marked contrast, this antibody detected significant conformational differences in the F protein at cell surfaces,
differences that depended upon HN protein expression. The antibody minimally detected the F protein, either
cleaved or uncleaved, in the absence of HN protein expression. However, when coexpressed with HN protein,
an uncleaved mutant F protein bound the anti-HR1 antibody, and this binding depended upon the coexpression
of specifically the NDV HN protein. When the cleaved wild-type F protein was coexpressed with HN protein,
the F protein bound anti-HR1 antibody poorly although significantly more than F protein expressed alone.
Anti-HR1 antibody inhibited the fusion of R18 (octadecyl rhodamine B chloride)-labeled red blood cells to
syncytia expressing HN and wild-type F proteins. This inhibition showed that fusion-competent F proteins
present on surfaces of syncytia were capable of binding anti-HR1. Furthermore, only antibody which was added
prior to red blood cell binding could inhibit fusion. These results suggest that the conformation of uncleaved
cell surface F protein is affected by HN protein expression. Furthermore, the cleaved F protein, when coex-
pressed with HN protein and in a prefusion conformation, can bind anti-HR1 antibody, and the anti-HR1-
accessible conformation exists prior to HN protein attachment to receptors on red blood cells.
The entry of Newcastle disease virus (NDV), a prototype
paramyxovirus, is directed by two virion glycoproteins, the
hemagglutinin-neuraminidase (HN) protein and the fusion (F)
protein (12). HN protein, the virus attachment protein, binds
to sialic acid-containing receptors, and F protein mediates
membrane fusion. In contrast to many viral fusion proteins,
paramyxovirus F proteins do not require the acid pH of endo-
somes to activate fusion activity. As a consequence, infected
cells expressing both attachment proteins and F proteins can
fuse with adjacent cells to form multinuclear cells, or syncytia,
a process that is assumed to mimic virus-cell fusion (12).
The NDV fusion protein is synthesized as a 553-amino-acid
precursor, F0 (5, 15). The mature F protein is a homotrimer
(24). Fusion activity of the protein requires a proteolytic cleav-
age of F0 at amino acid 117 to produce disulfide-linked F2 and
F1 polypeptides derived from the amino-terminal and carbox-
yl-terminal domains, respectively (12). The F1 polypeptide has
several domains important for fusion activity. The protein has
one and perhaps two fusion peptides (20), one located at the
amino terminus of the F1 polypeptide (reviewed in reference
12) and the other at a more internal location (20). Upon
activation of fusion, fusion peptides are thought to insert into
target membranes docking the protein to these membranes
(reviewed in references 4, 6, and 21). Paramyxovirus F1 pro-
teins have two heptad repeat (HR) regions, one (HR1) located
just carboxyl terminal to the more amino-terminal fusion pep-
tide and the other adjacent to the transmembrane domain
(HR2) (reviewed in references 11 and 12). Mutational analyses
of both the NDV HR1 and HR2 domains have shown that both
domains are important in the fusion activity of the protein (16,
23, 25, 29). These domains have also been implicated in fusion
activity by analysis of the structure and function of peptides
with sequences of these domains (8, 13, 22, 37–39). Results of
these studies, as well as similar studies of human immunode-
ficiency virus and influenza virus (4), have led to the hypothesis
that fusion proteins are synthesized and transported to cell
surfaces in a metastable conformation. In this conformation
the HR domains are not associated and the fusion peptide is
masked (4, 21, 36). Upon fusion activation, the F proteins are
thought to undergo a series of conformational changes that
result in insertion of fusion peptides into target membranes
and the interaction of the HR1 and HR2 domains to form a
very stable complex (1, 4, 21). This structure is a six-stranded
coiled coil composed of a central core trimer of HR1 domains
with three HR2 domains bound to the surfaces of the core
trimer (1, 40). The formation of this coiled coil is thought to
pull target and attack membranes into close proximity, allow-
ing subsequent fusion events (1, 40).
The attachment protein is required for fusion in most
paramyxovirus systems, since most F proteins expressed alone
do not mediate membrane fusion (11). It is also clear that HN
protein provides more than an attachment function, since mu-
tations in the HN protein stalk domain can retain attachment
activity but are defective in fusion promotion (26, 27, 30). The
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HN protein and the F protein must be from the same virus,
with a few exceptions, indicating that virus-specific interactions
between HN and F proteins (7) are required for fusion di-
rected by the F protein. It has been proposed that the attach-
ment of HN protein to its receptor serves to activate the F
protein (11). The nature of this activation is, however, unde-
fined.
With the goal of defining conformational changes in the F
protein during activation of fusion and the role of the HN
protein in those changes, we raised a polyclonal antibody
against a peptide with the sequence of the amino-terminal half
of the HR1 domain. This antibody allowed us to show that the
conformation of cell surface NDV F protein is altered by
coexpression of the HN protein. Evidence suggesting that HN
protein affects the conformation of F protein prior to both F
protein cleavage activation and attachment of HN protein to
its receptor is presented.
MATERIALS AND METHODS
Cells, viruses, and antibodies. Cos-7 cells, obtained from the American Type
Culture Collection, were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with nonessential amino acids, vitamins, penicillin, and
streptomycin, and 10% fetal calf serum. Stocks of NDV strains AV, a virulent
strain, and B1, an avirulent strain, (12, 19, 34), were grown in embryonated
chicken eggs and purified by standard protocols.
NDV F genes were inserted into pSVL (Pharmacia) as previously described
(29). The cleavage mutant F-K115G has been described (14). The Sendai virus
HN protein gene, obtained from D. Nayak, and the measles virus hemagglutinin
(HA) gene, obtained from M. Oldstone, each were inserted into pSVL.
Anti-NDV antibody was raised in rabbits against UV-inactivated stocks of
NDV strain AV by standard protocols. Anti-Ftail was raised against a synthetic
peptide with the sequence of the cytoplasmic domain of the F protein as previ-
ously described by Wang et al. (35) and prepared by the Peptide Core Facility of
the University of Massachusetts Medical School.
To raise anti-HR1 antibody, sequences encoding amino acids 132 to173 were
prepared by PCR using a primer containing a BamHI site and a primer with an
EcoRI site as well as the appropriate F protein gene sequences. The PCR
product was cloned into BamHI-EcoRI-cut pGex-2T (Pharmacia), and the li-
gated product was transformed into BL21 (Stratagene). BL21 cells containing
the plasmid were induced with IPTG (isopropyl--D-thiogalactopyranoside; 0.1
mM) for 3 h at 37°C. The cells were pelleted and lysed with BugBuster (Nova-
gen) by using protocols recommended by the manufacturer, and the glutathione
S-transferase (GST) fusion protein was purified with GST-Bind resin (Novagen)
by standard protocols. The purified, concentrated fusion protein was used for
production of antisera by Capralogics (Hardwick, Mass.).
Transfections. Transfections using Lipofectamine (Invitrogen) were done as
recommended by the manufacturer. Briefly, Cos-7 cells were plated at 3  105
per 35-mm plate. Twenty hours later, the cells were transfected. For each 35-mm
plate, mixtures of DNA in 0.1 ml of OptiMEM (BRL/Gibco) and 10 l of
transfection reagent in 0.2 ml of OptiMEM were incubated at room temperature
for 40 min, diluted with 0.7 ml of OptiMEM, and added to a plate previously
washed twice with 2 ml of OptiMEM. Cells were incubated for 5 h, DNA was
removed, and 2 ml of supplemented DMEM was added. Transfection mixtures
contained 0.5 g of each DNA/35-mm plate, but all transfection mixtures con-
tained a total of 1 g of DNA/35-mm plate. When pSVL-Fwt or pSVL-F-K115G
was expressed alone, 0.5 g of vector was also added to keep DNA concentra-
tions the same in all transfections.
Radiolabeling and immunoprecipitation of protein. At 48 h posttransfection,
cells were radiolabeled for 2 h at 37°C in DMEM lacking methionine but
containing 100 Ci of [35S]methionine (Amersham) per ml. For a nonradioactive
chase, cells were placed in complete medium. For infected cells, virus was added
at a multiplicity of infection of 15. Cells were radioactively labeled at 5 h
postinfection as described for transfected cells. At the end of the labeling period,
cells were washed in PBS and lysed in RSB buffer (0.01 M Tris-HCl [pH 7.4], 0.01
M NaCl) containing 1% Triton X-100, 0.5% sodium deoxycholate, 2 mg of
N-ethyl maleimide per ml, and 0.2 mg of DNase per ml. Immunoprecipitation of
NDV proteins was immediately accomplished as previously described (28, 30).
Immunofluorescence of live cells. Cos-7 cells were plated on 35-mm plates
containing glass coverslips and transfected as described above. Forty-eight hours
after transfection, cells were incubated at 4°C in primary unlabeled antibody
diluted in phosphate-buffered saline (PBS) containing 1% bovine serum albumin
(BSA) and 0.02% sodium azide for 1 h. Cells were then washed three times with
PBS containing BSA and azide and incubated for 1 h with anti-rabbit immuno-
globulin G (IgG) coupled to Alexa-488 (Molecular Probes) diluted in PBS-BSA-
azide. Cells were washed in ice-cold PBS-BSA-azide and then fixed in 1%
paraformaldehyde. Coverslips were mounted on slides, and cells were photo-
graphed immediately with a Nikon Diaphot 300 fluorescence microscope.
Flow cytometry. Transfected cells were incubated overnight in DMEM without
CaCl2. Cells were removed from plates with cell detachment buffer (Sigma Co.),
washed in PBS containing 1% BSA and 0.02% azide (fluorescence-activated cell
sorting [FACS] buffer) and then incubated with anti-HR1 antibody for 1 h at 4°C
(1/200 dilution). After cells had been washed three times with FACS buffer, they
were incubated for 1 h at 4°C with goat anti-rabbit IgG coupled to Alexa-488
(Molecular Probes). After incubation, cells were washed, resuspended in PBS
containing 2% paraformaldehyde, and subjected to flow cytometry (University of
Massachusetts Medical School Flow Cytometry Facility). Cells transfected with
vector alone and incubated with both primary and secondary antibody were used
as controls.
Fusion assays using R18-labeled RBC. The protocol used for fusion assays was
similar to that previously described (9, 10). Briefly, avian red blood cells (RBC)
(Crane Laboratories) were washed in PBS and then incubated with 15 g of R18
(octadecyl rhodamine B chloride) (Molecular Probes) per ml for 30 min at room
temperature in the dark. Three volumes of complete medium (DMEM with 10%
fetal calf serum) were added, and incubation was continued for 30 min. The RBC
were then washed four times in ice-cold PBS, resuspended in PBS containing
CaCl2 (0.01%), and added to transfected cells that had been grown on coverslips
and washed in PBS with CaCl2. Transfected cells were incubated with labeled
RBC for 30 min on ice. Cells were washed with ice-cold PBS containing CaCl2
and then incubated at 37°C. After incubation, cells were washed in cold PBS
containing CaCl2 and immediately visualized and photographed with a Nikon
Diaphot 300 fluorescence microscope.
RESULTS
Immunoprecipitation of F protein from cell lysates. The
nucleic acid sequence encoding the amino-terminal region of
the NDV F protein HR1 domain (amino acids 132 to 173) (Fig.
1) was cloned in frame at the carboxyl terminus of the gene
encoding GST, and the resulting fusion protein was expressed
in Escherichia coli. Polyclonal antibodies against the purified
fusion protein were raised in rabbits. The HR1 sequences
chosen were derived from a region of the NDV F protein that
was not resolved in the crystal structure of the F protein (2).
However, results of mutagenesis of this region of the F protein
FIG. 1. F protein sequences used to raise antibody. A diagram of
the primary sequence of the NDV F protein with important domains is
shown. The sequence encoding amino acids 132 to 173 was cloned in
frame to the carboxyl terminus of GST. The resulting purified fusion
protein was used to raise antibodies. SS, signal sequence; FP, fusion
peptide; TM, transmembrane domain; CT, cytoplasmic domain.
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showed that it was clearly involved in the fusion activity of the
protein (25, 29).
The resulting polyclonal antibodies readily precipitated F
proteins from infected cell extracts. Figure 2A shows the pre-
cipitation of proteins from infected cell extracts pulse-labeled
with [35S]methionine as well as extracts derived from cells that
were pulse-labeled and subjected to increasing times of a non-
radioactive chase. Precipitation of proteins using a previously
characterized antibody specific for the cytoplasmic tail of the F
protein is also shown as a positive control. Clearly, the anti-
HR1 antibody precipitated the nascent F0 protein as well as
the F1-sized polypeptide that appeared during a nonradioac-
tive chase as the protein matured through the cell. The anti-
body did preferentially precipitate F0.
Similar results were obtained with extracts from transfected
cells (Fig. 2B). Cos cells were transfected with a gene encoding
FIG. 2. Immunoprecipitation of F protein from cell extracts. (A) Cells infected with NDV strain AV were radioactively labeled for 5 min
(P) and then subjected to a nonradioactive chase for the times (in minutes) indicated at the top. Proteins were immunoprecipitated using anti-Ftail
or anti-HR1. The proteins precipitated were resolved on 10% polyacrylamide gels in the presence of a reducing agent. Localization of viral proteins
in the polyacrylamide gel lane containing infected cell extracts (M, marker proteins) is noted for molecular weight markers. F0, uncleaved F
protein; F1, cleaved F protein; NP, nucleocapsid protein; M, membrane protein. (B) Cells were transfected with pSVL (vector), pSVL-Fwt,
pSVL-F-K115G, pSVL-Fwt plus pSVL-HN, or pSVL-F-K115G plus pSVL-HN (0.5 g of each DNA/35-mm plate of Cos cells). After 48 h, cells
were radioactively labeled for 2 h and chased in nonradioactive medium for 4 h. Proteins in cells extracts were precipitated with anti-Ftail or
anti-HR1.
12624 MCGINNES ET AL. J. VIROL.
 at UNIV O
F M
ASS M






the wild-type F protein, a protein with a furin recognition
sequence at the cleavage site, and a gene encoding F-K115G,
a protein with a mutation in the furin recognition site. Cells
transfected with the wild-type protein expressed both F0 and
the cleaved form of the fusion protein (F1), while the mutant
gene expressed only the F0 protein (14). In addition, both F
protein genes were cotransfected with a gene encoding the HN
protein. Clearly, anti-HR1 antibody precipitated both F0- and
F1-sized polypeptides from extracts expressing the wild-type F
protein whether or not the HN protein was expressed. The
anti-HR1 antibody also precipitated the F0 protein from ex-
tracts expressing the mutant uncleaved F protein, and HN
protein coexpression had little effect on the efficiency of pre-
cipitation.
Thus, in cell extracts in which membranes are dissolved with
detergent, the HR1 domain of the uncleaved F0 protein as well
FIG. 3. Surface immunofluorescence of NDV-infected cells. Cells infected for 6 h with NDV strain AV or strain B1, and uninfected cells were
incubated with either anti-HR1 or anti-NDV antibody as described in Materials and Methods. Cells reacted with anti-HR1 were exposed to films
for 4 s, while cells reacted with anti-NDV were exposed to film for 2 s. Fields shown are representative of the entire culture, and each field is
representative of at least three separate experiments.
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FIG. 4. Surface immunofluorescence of transfected cells. Cells transfected with pSVL (vector), pSVL-F-K115G, pSVL-F-K115G plus pSVL-
HN, pSVL-Fwt, or pSVL-Fwt plus pSVL-HN (0.5 g of each DNA/35-mm plate of Cos cells) were incubated with either anti-NDV or anti-HR1
as described in Materials and Methods. Film was exposed for 2 s (B, D, F, H, and J) or 3 s (A, C, E, G, and I). The field shown in panel I was
also exposed for 7 s (K). Fields shown are representative of the entire culture, and each is representative of at least four separate experiments.
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as the cleaved F1 polypeptide was accessible to antibody and
coexpression of the HN protein had little effect on the reac-
tivity of this domain to antibody.
Immunofluorescence of intact cells expressing the F protein.
Hypothesized conformational changes in the F protein associ-
ated with the onset of fusion occur in a membrane-associated
F protein. Therefore, we characterized anti-HR1 antibody
binding to F protein expressed on infected or transfected cell
surfaces. Figure 3 shows surface immunofluorescence of cells
infected with a virulent strain of NDV, which expresses pri-
marily the cleaved F protein (strain AV), and cells infected
with an avirulent strain of NDV which expresses only the
uncleaved F protein (strain B1). Clearly, cells infected with
either virus bound anti-HR1. However, cells infected with the
virulent strain of NDV were not as brightly fluorescent as cells
infected with the avirulent strain of NDV.
Figure 4 shows immunofluorescence of transfected cells.
Cells transfected only with the gene encoding F-K115G are
shown in Fig. 4C and D. Cells expressing only the uncleaved F
protein bound anti-HR1 antibody very poorly (Fig. 4C), al-
though cells transfected with this gene were clearly expressing
F protein, as shown by using anti-NDV antibody (Fig. 4D).
Surprisingly, cells expressing both the uncleaved F-K115G pro-
tein and the HN protein were strongly positive for anti-HR1
binding (Fig. 4E). This result was verified by FACS analysis
(Fig. 5B). Cells expressing the uncleaved F-K115G protein
alone were minimally reactive to anti-HR1, while cells express-
ing both the uncleaved F protein and the HN protein bound
antibody. Cells expressing F-K115G were, however, positive by
flow cytometry using anti-NDV antibody (data not shown).
This result is consistent with the idea that coexpression of HN
protein alters the conformation of F protein on cell surfaces.
Figures 4G and 5A show that, like uncleaved F protein,
cleaved cell surface wild-type F (Fwt) protein expressed alone
was unreactive to anti-HR1 antibody. The F protein was, how-
ever, accessible to binding anti-NDV antibody, as shown by
immunofluorescence (Fig. 4H) and by flow cytometry (Fig.
5C). The protein was also detected by immunofluorescence
and flow cytometry using anti-Fu1a, a monoclonal antibody
specific for the F protein (18, 27) (data not shown). Coexpres-
sion of HN protein with this F protein resulted in syncytia (Fig.
4J). While the syncytia did bind anti-HR1 antibody (Fig. 4I and
K), the intensity of fluorescence was significantly lower than
that seen with uncleaved F protein coexpressed with HN pro-
tein. Flow cytometry of cells expressing HN and F proteins was
not attempted because of the fragility of syncytia.
Immunofluorescence of intact cells expressing the F protein
FIG. 5. Detection of cell surface F protein by flow cytometry. At 48 h after transfection (0.5 g of each DNA/35-mm plate), cells were prepared
for FACS as described in Materials and Methods. (A and B) Anti-HR1 antibody; (C) anti-NDV antibody. (A) pSVL (vector), pSVL-Fwt, and
pSVL-F-K115G; (B) pSVL and pSVL-F-K115G plus pSVL-HN; (C) pSVL (vector) and pSVL-Fwt. FL1-H, fluorescence. The results are
representative of four different experiments.
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in the presence of heterologous attachment proteins. It was
possible that the effect of HN protein on accessibility of the F
protein to anti-HR1 antibody was unrelated to the fusion pro-
motion activity of the HN protein. For example, the neuramin-
idase activity of the HN protein could increase the accessibility
of the F protein by removal of sialic acid from cell surfaces. We
therefore determined if the effect of HN protein expression on
F protein conformation was virus specific by coexpressing the
NDV F protein with the HA protein of measles virus (Fig. 6D)
or the HN protein of Sendai virus (Fig. 6E). Binding of the
anti-HR1 antibody to the uncleaved F protein expressed with
the heterologous attachment proteins was similar to that ob-
served when F protein was expressed alone (Fig. 6B) and much
less than that observed when F protein was expressed with the
NDV HN protein (Fig. 6C).
We also found that binding of anti-HR1 antibody to F pro-
tein that had been either cleaved or uncleaved and expressed
alone was not increased by prior treatment of cells with neur-
aminidase (data not shown).
Inhibition of fusion by anti-HR1 antibody. The decreased
binding of anti-HR1 to cells expressing the cleaved F protein
with HN protein may indicate that the antibody will only bind
residual uncleaved F protein at cell surfaces. Alternatively,
anti-HR1 may bind a cleaved form of the F protein present in
smaller amounts, such as F protein in a prefusion conforma-
tion. Syncytia expressing both HN protein and the cleaved F
protein likely contain a significantly reduced population of F
protein molecules that remain in such a prefusion conforma-
tion. However, if there are such molecules present and if anti-
HR1 can bind to them, then the anti-HR1 antibody may inhibit
fusion mediated by these molecules.
To determine whether anti-HR1 antibody could inhibit the
fusion activity of the F protein, we characterized the effect of
antibody on the fusion of RBC with Cos-7 cells coexpressing
the HN and F proteins. Initial steps in fusion can be monitored
by the transfer of fluorescence-labeled lipid from RBC mem-
branes to the membranes of cells expressing viral fusion pro-
teins, as shown in Fig. 7. Cos cells transfected with genes
encoding the HN protein and the wild-type F protein form
large syncytia which will bind RBC (data not shown). Upon
incubation at 37°C in the presence of anti-NDV antibody, no
fusion was observed (Fig. 7A), while during incubation at 37°C
without antisera, transfected cells fused with the RBC and the
fluorescence-labeled lipid in RBC spread into the syncytia
(Fig. 7B). Over 80% of syncytia were positive for fusion with
RBC (Fig. 7E). This result shows that there are F proteins
expressed on the surfaces of the syncytia that are capable of
directing fusion upon binding of the RBC and are therefore in
a prefusion conformation.
To determine if anti-HR1 antibody could inhibit this fusion,
the antibody was present prior to, during, and after RBC bind-
ing. The antibody did not interfere with RBC binding (data not
shown). The antibody clearly inhibited fusion of the RBC with
syncytia (Fig. 7C and E). Over 80% of all syncytia were nega-
tive for fusion after incubation at 37°C. This inhibition is not
due to a nonspecific effect of IgG, since addition of preimmune
sera did not inhibit RBC fusion with syncytia (Fig. 7D and E).
Inhibition of fusion by anti-HR1 antibodies could be due to
antibody binding before or after attachment of RBC to cell
surfaces. To determine when the binding site was accessible
relative to attachment, antibody was added to monolayers of
cells cotransfected with HN and Fwt cDNAs only prior to RBC
binding, only during RBC binding, or only after RBC binding
(Fig. 8). Clearly, if antibody was present only prior to RBC
binding, fusion was inhibited (Fig. 8B and E). If antibody was
present only during RBC binding, fusion was also inhibited
FIG. 6. Surface immunofluorescence of cells transfected with heterologous attachment proteins. Cells were transfected with DNA encoding
F-K115G or cotransfected with F-K115G and either NDV HN protein, Sendai virus (SV) HN protein, or measles virus (MV) HA protein. After
48 h, cells were incubated with anti-HR1 antibody and then goat anti-rabbit antibody coupled to a fluorescence dye as described in Materials and
Methods. (A) Vector; (B) pSVL-F-K115G; (C) pSVL-F-K115G plus pSVL-HN (NDV); (D) pSVL-F-K115G plus pSVL-MV HN; (E) pSVL-F-
K115G plus pSVL-SV HA. All panels show 2-s exposures. Fields shown are representative of the entire culture.
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(Fig. 8C and E). However, if antibody was present only after
RBC binding, there was less inhibition (Fig. 8D and E). These
results were quantitated at three times after incubation at 37°C
(Fig. 8E). These results show that antibody can inhibit if bound
only prior to the attachment of RBCs to the surfaces of HN
and F protein-expressing cells. Furthermore, inhibition is
greater than that observed if antibody is added only after
RBC.
DISCUSSION
It has been hypothesized that, like other fusion proteins, the
paramyxovirus F protein is folded into a metastable conforma-
tion, and, upon activation of fusion, the F protein undergoes a
cascade of conformational changes resulting in the formation
of a very stable, six-stranded coiled coil composed of HR1 and
HR2 domains (2). To explore potential conformational
FIG. 7. Inhibition of fusion by anti-HR1 antibody. At 48 h after transfection of Cos cells with pSVL-Fwt and pSVL-HN, monolayers were
incubated with R18-labeled RBC on ice in the absence of antibody followed by the addition of anti-NDV and incubation for 1 h at 37°C (A) or
on ice followed by incubation at 37°C for 1 h in the absence of antisera (B). (C) Cells coexpressing HN and F proteins that were incubated with
anti-HR1 on ice for 30 min, followed by incubation on ice with anti-HR1 and RBC for 30 min and then by incubation at 37°C for 1 h in the presence
of anti-HR1. (D) Cells were treated similarly to those in panel C except that a preimmune serum was used. Each field shows a single syncytium.
(E) Quantitation of results. Each column represents at least 300 syncytia counted in three separate experiments. Ab, antibody.
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changes in the F protein during onset of fusion and the role of
the HN protein in that process, we characterized the binding
and fusion inhibition of antibody specific for the HR1 domain
of the NDV F protein. This antibody immunoprecipitated the
F0 and F1 forms of the protein from cell extracts solubilized
with detergent, and precipitation of F protein was unaffected
by expression of the HN protein. Antibody against a compa-
rable domain of the simian virus 5 (SV5) F protein was raised
and would precipitate only the uncleaved form of the protein
(3). This different result may be attributed to differences in the
conformation of the NDV F protein and the SV5 F protein in
cell lysates. The anti-HR1 antibody raised against NDV se-
quences did preferentially precipitate the uncleaved F protein.
Furthermore, we observed that precipitation of F1 was prefer-
entially lost as cell extracts “aged,” suggesting conformational
changes in the cleaved F protein after cell lysis masked the
HR1 domain in the cleaved form of the protein. For these
reasons, immunoprecipitation was performed immediately
upon cell lysis.
In contrast to results obtained with cell extracts, anti-HR1
antibody minimally detected F protein expressed on cell sur-
faces, either cleaved or uncleaved, in the absence of HN pro-
tein expression. This result suggested that without HN protein
expression, the membrane-associated F protein was folded so
that the HR1 domain was inaccessible to antibody binding.
Perhaps in the absence of HN protein, the F protein folds into
a more stable conformation in which the HR1 domain is
masked rather than the metastable form that can initiate fu-
sion. Such an interpretation is consistent with the observation
that wild-type NDV F protein cannot initiate fusion, even at
low levels, in the absence of HN protein expression (17, 27).
In striking contrast, the uncleaved F protein coexpressed
with HN protein bound the anti-HR1 antibody, and this bind-
ing depended specifically upon the coexpression of NDV HN
protein. Binding was not observed in the presence of the mea-
sles virus HA protein or the Sendai virus HN protein. This
result suggests that F protein expressed with HN protein is
folded so that the HR1 domain is accessible to antibody and is,
therefore, in a conformation different from that of F protein
expressed alone. Since fusion cannot occur prior to F protein
cleavage, this result also suggests that the conformational dif-
ferences in the F protein due to coexpression of HN protein
are manifested prior to cleavage activation of fusion. Indeed, it
has been reported that HN protein and uncleaved F protein
coimmunoprecipitate, a result that suggests an interaction be-
tween HN protein and uncleaved F protein (31).
The wild-type, cleaved F protein, coexpressed with HN pro-
tein, bound anti-HR1 antibody poorly, although significantly
more than cleaved F protein expressed alone. The low level of
binding may be due to residual uncleaved F protein on cell
surfaces. Another possibility (not mutually exclusive with the
first) was that only one of several forms of the cleaved F
protein was accessible to anti-HR1 binding. Cleaved F protein
in the presence of HN protein may exist in at least two forms
on cell surfaces, one in a prefusion form and the other in a
postfusion form. It is proposed that in the postfusion confor-
mation, the HR1 domain forms the interior trimer of the
six-stranded HR1-HR2 complex (1, 3); thus, it is reasonable to
suppose that the HR1 domain is inaccessible to antibody in this
conformation. Indeed, Dutch et al. have presented evidence
suggesting that the SV5 HR1 domain is inaccessible to a pep-
tide antibody in the six-stranded coiled-coil complex (3). If
much of the cleaved F protein exists in this postfusion confor-
mation, there would be only low-level anti-HR1 binding, as was
observed. To explore the possibility that the prefusion form of
the protein could bind antibody, we determined if anti-HR1
antibody could block fusion. Indeed, RBC fused with syncytia
expressing the HN and wild-type F proteins; thus, a population
of F protein on syncytium surfaces is capable of directing
fusion. Importantly, anti-HR1 antibody inhibited this fusion.
This result is consistent with the idea that the fusion-compe-
tent, cleaved F protein on the syncytium surfaces was accessi-
ble to anti-HR1 antibody in the presence of HN protein.
Two models have been proposed for the role of HN protein
in fusion (Fig. 9), models that differ in the role of attachment
in inducing conformational changes in F protein. Model 1
proposes that HN and F proteins interact only after HN pro-
tein receptor binding and this interaction initiates F protein
conformational changes required for fusion (11, 17). In this
model, conformational differences in F protein in the presence
and absence of HN protein should be manifested only after
HN protein attachment. An alternative model is that HN and
F proteins form a metastable complex prior to HN protein
attachment (31–33), a complex that prevents the HR1-HR2
interactions that would occur in F proteins expressed without
HN protein. HN protein attachment with a concomitant con-
formational change releases the F protein and thus stimulates
the cascade of F protein conformational changes required for
fusion, changes that result in the formation of the six-stranded
coiled coil composed of HR1 and HR2 domains. In this model,
conformational differences in F protein in the presence and
absence of HN protein should be manifested prior to HN
protein attachment.
Since anti-HR1 antibody detected a conformational differ-
ence between F proteins expressed with and without HN pro-
tein, we asked when this conformational difference was mani-
FIG. 8. Anti-HR1 antibody bound prior to RBC addition inhibits fusion. Shown is fusion of R18-labeled RBC to cells expressing HN and F
proteins in the presence of anti-HR1 antibody (Ab) added at different times relative to the RBC. At 48 h after transfection of Cos cells with
pSVL-Fwt and pSVL-HN, monolayers were incubated with R18-labeled RBC with or without antibody followed by incubation at 37°C. (A) Cells
without added antibody. (B) Cells incubated with anti-HR1 antibody on ice for 30 min only prior to addition of RBC. These cells were washed
three times to remove unbound antibody and then were incubated with R18-labeled RBC on ice for 30 min followed by incubation at 37°C.
(C) Cells incubated with RBC and antibody together. Both unbound antibody and RBC were removed in three washes, and cells were incubated
at 37°C. (D) Cells incubated with RBC on ice. Unbound RBC were removed, anti-HR1 antibody was added, and then the cells were shifted to 37°C.
(E) Cells transfected with HN and F protein cDNAs were treated as for panels A to D, and the percentage of syncytia fused to RBC was
determined after 10, 20, or 30 min at 37°C. Each point is the result for over 100 syncytia. The data are the combined results of three separate
experiments.
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fested, before or after HN protein attachment. We asked when
the antibody could inhibit fusion relative to the binding of
RBC. Clearly, inhibition occurred if antibody was bound prior
to RBC addition. This result is consistent with the idea that the
HR1 domain is accessible prior to attachment. Furthermore
the inhibition was greater than that observed when antibody
was added after the RBC, particularly during the earlier times
of incubation at 37°C. That antibody added only prior to RBC
binding could inhibit fusion is more consistent with model 2.
However, we cannot exclude the possibility that antibody
bound to postactivation forms of the F protein indirectly in-
terferes with conformational shifts in the prefusion form of the
protein.
These combined results are most consistent with model 2
(Fig. 9). F protein, either cleaved or uncleaved and coex-
pressed with HN protein, is folded into a conformation in
which the HR1 domain is accessible to antibody binding. Upon
attachment of HN protein to its receptor, the F protein ini-
tiates conformational changes necessary for the close approach
of the two membranes, conformational changes that mask the
HR1 domain. In contrast, F protein expressed alone folds into
a conformation in which the HR1 domain is inaccessible to
anti-HR1 antibody.
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